戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 eptor together with enhanced levels of TRAIL death receptor 4.
2 d apoptosis-inducing ligand (TRAIL) binds to death receptors 4/5 and selectively induces caspase-depe
3 c (BM) capability and overexpresses EGFR and death-receptors 4/5 (DR4/5); however, the anatomical loc
4    Despite the expression of TRAIL receptors death receptor 4 and death receptor 5, purified TRAIL co
5 s-inducing ligand (TRAIL) and its receptors, death receptor 4 and death receptor 5, which were up-reg
6  surface expression of both TRAIL receptors, death receptors 4 and 5 (DR4 and -5).
7                           Hsp70 was bound to death receptors 4 and 5 (DR4 and DR5) and inhibited Apo-
8 and functions by activating the cell surface death receptors 4 and 5 (DR4 and DR5).
9        NO* treatment did not alter levels of death receptors 4 and 5, Fas-associated death domain or
10 rough two receptors, TRAIL-R1 (also known as death receptor 4) and TRAIL-R2 (also known as death rece
11 uces apoptosis through its cognate receptors death receptor 4 (DR4) and death receptor 5 (DR5), prefe
12 genes but also proapoptotic genes, including death receptor 4 (DR4) and death receptor 5 (DR5).
13 regulates the expression of TRAIL receptors: death receptor 4 (DR4) and death receptor 5 (DR5).
14                The interaction of TRAIL with death receptor 4 (DR4) and DR5 can trigger apoptotic cel
15  protein that interacts with five receptors: death receptor 4 (DR4) and DR5 mediate apoptosis activat
16  ligand (TRAIL) and its functional receptors death receptor 4 (DR4) and DR5.
17                                              Death receptor 4 (DR4) is a recently described receptor
18                                              Death receptor 4 (DR4) is one of the tumor necrosis fact
19 , tumor necrosis factor receptor 1 (TNF-R1), death receptor 4 (DR4), and DR5.
20 ucing ligand wild type (rhTRAIL(WT)) and its death receptor 4 (DR4)-specific variant rhTRAIL(4C7) in
21 in cancer, we developed murine mAbs to human death receptor 4 (DR4).
22  receptors (DcR1 and DcR2) co-expressed with death receptor 4 (DR4)/DR5 on the same cell can block th
23 leavage of MEKK1 and increased expression of death receptor 4 (DR4, TRAILR1) and death receptor 5 (DR
24                                              Death receptor 4 (DR4; also called TRAIL-R1), a member o
25  Computational analysis identified the TRAIL Death Receptor-4 (DR4) as a potential novel miR-25 targe
26 the extrinsic apoptoticpathway by binding to death receptors 4 (DR4) and 5 (DR5).
27 apoptosis in susceptible cells by binding to death receptors 4 (DR4) and 5 (DR5).
28 e-mediated increase in the expression of the death receptors 4 (DR4) and 5 (DR5).
29 ember of the TNF-receptor family (designated death receptor-4, DR4) that contains a cytoplasmic "deat
30  The TRAIL receptor (TRAIL-R1; also known as death receptor 4) is a transmembrane receptor that media
31 is-inducing ligand (TRAIL) and its receptor, death receptor 4, sensitizing cells to an autocrine loop
32 of the cell lines expressed TRAIL receptor 1/death receptor 4 (TRAIL-R1/DR4) and TRAIL-R2/DR5.